Sofinnova Partners SAS. SEC USE ONLY: 4. All Sofinnova Partners SAS holdings are listed in the following tables. About Sofinnova Partners SAS Sofinnova Partners operates as an investment management company. New York, NY 10001. Expand your fundraising pool and make warm introductions to potential new business connections. any kind between RelSci and Sofinnova Partners SAS. Date Founded. Whalewisdom has at least 10 13G filings This represents 7.1 percent ownership of the company. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital. HighLife SAS | Sofinnova Partners HighLife SAS, headquartered in Paris, France, with offices in Irvine (California), is an early-stage company established in 2010. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any. Sofinnova Partners SAS, a French corporation (“SP SAS”) 2. Sofinnova Partners SAS is listed as an insider in the following companies: HOOK / HOOKIPA Pharma Inc. BIOA / BioAmber Inc. FLXN / Flexion Therapeutics, Inc. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ 6. Industries. The use of any trade name or trademark is for identification and Transaction date: between Mar 27, 2019 and Mar 27, 2021, Name: SOFINNOVA PARTNERS SAS. Certain Information provided by Factset Research System Inc. SK Innovation reaches deal with LG Chem in trade secret dispute, 'Jim Crow' criticism of Georgia voting law doesn't fit, Trinity Rodman scores on NWSL debut and Scotty Pippen Jr declares for NBA draft. Mainstay Medical Announces US$108 Million Equity Financing Transaction; Funding to support U.S. commercial launch and global expansion, Roche joins Sofinnova, AbbVie in Enthera's €35M venture round, Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of (EURO)35m, Noema bags $60M to take ex-Roche CNS drugs through phase 2b, Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners. Contact Sofinnova today. This web site is not endorsed by, directly affiliated with, maintained, authorized, or Consult company data for SOFINNOVA PARTNERS SAS (0675.571.346) from Belgium or for other companies in the sector Other. Sofinnova Partners SAS is based out of Paris. Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Discover the Power of Your Network with RelSci Premium Products. The firm invests primarily in early-stage companies and corporate spin-offs, in industrial biotechnology and in life sciences.. The firm manages over €2 billion of assets dedicated to life science investing and actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to The technology aims at a beating heart procedure reducing trauma to the patients. Sofinnova Partners SAS Sofinnova Partners is an active manager which invests exclusively in life sciences and information technology firms in France, Europe, and to a limited extent, the US. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. 5. Based in Paris, France, with offices in London and Milan, the firm brings together a team of 40 professionals from all over Europe, the U.S. and Asia. The Sofinnova Partners' flagship fund, Sofinnova Capital IX, raised €333M in 2019. Headquarters. reference purposes only and does not imply any association with the trademark holder. Sara Núñez-Garcia, PhD, MBA Sara Núñez-Garcia joined the Life Sciences team as an Associate in 2013; Sara focuses on investments in the biopharmaceutical sector. In the past Dr. Hong was Portfolio Manager & Analyst at Exane Asset Management SA and Research Associate at Citigroup Global Markets, Inc. (Broker). Managing Partner & Chief Operating Officer, Novo Nordisk A/S purchases Corvidia Therapeutics, Inc. from Sofinnova Partners SAS, Andera Partners SCA, Apple Tree Partners, Zambon Company SpA, Zambon Spa purchase Breath Therapeutics GmbH from Sofinnova Partners SAS, Gimv (Private Equity), Gilde Healthcare Partners BV, Otsuka Holdings Co., Ltd. purchases ReCor Medical, Inc. from Sofinnova Partners SAS, Advised onSofinnova Partners SAS purchases Sensitive Object SA, Advised onClovis Oncology, Inc. purchases EOS SpA from Sofinnova Partners SAS. 7-11 blvd Haussmann. Citizenship or Place of Organization . The company was founded in 2011 and is headquartered in Paris, France. Sofinnova Partners SAS. Biography. It is a privately held portfolio company of Sofinnova Partners, financed through the MD Start III Fund. It is focused on the development of a novel transcatheter replacement system for treating mitral regurgitation. They a minimum of 0.5 million euros per investment, and up to 20 million euros over several rounds of financing.Sofinnova acts as lead or co-lead investor, taking a seat on the board of directors and seeking to bring added value to the investee company management team. Sofinnova Partners SAS (hereinafter “Sofinnova”) is a leader in global life sciences and healthcare venture investing. 3000 Sand Hill Road, Building 4, Suite 250 Menlo Park, CA … Sofinnova Partners SAS Sofinnova Partners operates as an investment management company. All Rights Reserved. 75009 Paris. Anne Osdoit is Partner:Mdstart Fund at Sofinnova Partners. Elle rejoint Sofinnova en 1983 et débute son expérience en assurant le suivi des fonds américains. Sofinnova Partners SAS discloses 7.10% ownership in PRQR / ProQR Therapeutics N.V. 2019-02-14 - Sofinnova Partners SAS has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,764,194 shares of ProQR Therapeutics N.V. (US:PRQR). Empower Your Business Applications with Industry-Leading Relationship Data from the RelSci API. Check the Appropriate Box if a Member of a Group (see instructions) (a) ¨ (b) S. 3. 5 Pennsylvania Plaza 15th Floor A. Sofinnova Partners SAS Sofinnova Partners is an active manager which invests exclusively in life sciences and information technology firms in France, Europe, and to a limited extent, the US. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward. /s/ Monique Saulnier, Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SAS: Sofinnova deploys human and financial capital to turn dreams into drugs. Looking for a partner with proven experience in medicine, investment and operations? France +33 1 76 23 41 09 (Name, Address and Telephone Number of Person. France +33 1 76 23 41 09 (Name, Address and Telephone Number of Person. Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any. Antoine Papiernik is a Managing Partner at Sofinnova Partners, which he joined in 1997. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you. They also have expertise in the clean technology sector. Find RelSci relationships, employment history, board memberships, donations, awards, and more. The estimated Net Worth of Partners Sas Sofinnova is at least $23.9 Million dollars as of 29 October 2014. Kinam Hong occupies the position of Partner at Sofinnova Partners SAS. Moon Surgical | Sofinnova Partners Moon Surgical (previously MastOR SAS) is a Paris-based, early stage medical device company, developing a surgical robot for laparoscopy assistance. Net Worth and Insider Trades. Sofinnova Partners invests across the entire value chain of life sciences investments, from seed to later-stage. This page shows the track record and history of Sofinnova Partners SAS insider trades in HOOKIPA Pharma Inc.. Employees (Worldwide) 11 - 50. CorWave SA develops and manufactures blood pumps. Dr. Hong is also on the board of Abivax SA. All Rights Reserved. 75009 Paris. Partners Sofinnova owns over 10,000 units of Flexion Therapeutics Inc stock worth over $23,700,003 and over the last 7 years Partners sold FLXN stock worth over $200,000. Relationship Science Type of Company. Monique Saulnier est partenaire-associé et COO de Sofinnova Partners. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.